Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001057430 | SCV001221924 | likely benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002482019 | SCV002785032 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2021-12-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455257 | SCV004182137 | uncertain significance | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271139 | SCV004182138 | uncertain significance | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003890203 | SCV004707869 | likely benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001271139 | SCV001451993 | uncertain significance | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |